NewsBenzinga구겐하임, 에디타스 메디신 투자의견 ‘매수’로 상향 조정 및 목표주가 5달러 제시 구겐하임, 에디타스 메디신 투자의견 ‘매수’로 상향 조정 및 목표주가 5달러 제시 Benzinga 2026.09.23 12:29 (GMT+0) Open on Benzinga Other news Dollar rises to eight-week high as Fed rate hike expectations heat up Stocks Slip on Higher Bond Yields and Weakness in Chipmakers Optimism partners with Korea's KB Securities and Securitize to advance institutional tokenization 3 days left to save up to $200 and make impactful connections at TechCrunch Disrupt 2026 Galaxy Adds $100 Million of sUSDS to Treasury, Approves It as Loan Collateral These stocks are the ‘four horsemen of AI’ — and they’re not the ones you’d think
